Revolution Medicines · 6 hours ago
Director, Global Marketing
San Francisco Bay Area
Full-time
Hybrid
Director/Executive
$211K/yr - $264K/yr
8+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Director of Global Marketing will lead the global brand strategy for the company's lead molecule for pancreatic cancer, working closely with cross-functional teams to execute go-to-market plans and ensure successful product launch.
Health CareLife ScienceMedical
Responsibilities
Lead the development of critical aspects of the global brand strategy and multi-year commercial plan (annual plan and long-range plan inputs) for priority assets, integrating customer, patient, and market insights into actionable strategic choices
Shape the global positioning, value proposition, and messaging architecture; build and maintain the global promotional platform to enable consistent, compliant communications across markets
Partner to inform insight generation plans across disease state, customer segments, and treatment paradigms, informing primary market research, competitive intelligence, and patient journey mapping
Partner with Global Medical Affairs and Clinical Development to translate clinical data into impactful, accurate, and compliant scientific narratives; provide commercialization perspective on evidence generation, publication planning inputs, and congress strategy
Partner with Global Market Access colleagues to ensure brand strategy incorporates pricing, reimbursement, and access considerations; guide the development of payer value messages and value evidence (e.g., HEOR, RWE) plans
Lead critical components of global launch readiness, including critical path planning, milestone management, and risk mitigation to enable on-time, on-strategy execution
Develop and deploy global core assets and tools (e.g., brand story, core claims and substantiation, visual identity guidance, unbranded disease education, HCP/patient education frameworks, digital content standards), enabling efficient localization by areas and affiliates
Support diagnostics and patient finding strategy for biomarker-driven oncology, including alignment with companion diagnostic plans, testing pathways, and stakeholder education
Manage agency of record and vendor relationships and workflows; develop scopes of work, set performance expectations, and ensure high-quality, on-time deliverables
Own key components of global marketing budget for assigned programs; track spend, forecast, and ensure delivery within budget and in alignment with company policies
Define success metrics (e.g., awareness, adoption drivers, HCP behavior change, digital performance where applicable) and partner with Global Analytics and Insights to build dashboards and incorporate learnings into plan updates
Ensure all strategic and tactical activities meet compliance, regulatory, and company policy requirements; model a culture of integrity and patient-first decision making
Travel as needed (typically up to 25-30%)
Qualification
Required
Bachelor's degree required; advanced degree (MBA, PhD, PharmD, or equivalent) preferred
At least 8-10 years of progressive commercial experience in biotechnology and/or pharmaceuticals, including global strategic marketing or global brand responsibilities; local/affiliate marketing experience is a plus
Demonstrated track record developing and executing global brand strategies and translating insights into executable plans and deliverables
Launch experience (global, regional, or major market) with responsibility for core brand strategy, messaging, and enabling assets
Strong understanding of the oncology ecosystem, including key stakeholders (patients, caregivers, HCPs, institutions, payers, diagnostics stakeholders) and the ability to quickly learn complex disease areas, treatment pathways, and competitive landscapes
Proven ability to lead cross-functional teams in a matrix environment and influence across an organization at all levels without direct authority
Demonstrated ability to operate effectively in a smaller, rapidly growing company
Possess an entrepreneurial mindset, with tolerance for ambiguity, strong bias towards action, and a passion for impacting the lives of cancer patients
Demonstrated ability to derive insights/analytics leading to the development of innovative market strategies
Ability to represent Revolution Medicines externally with professionalism and credibility
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase